" class="no-js "lang="en-US"> Robyn Tolley - Medtech Alert
Tuesday, July 29, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Robyn Tolley

Robyn Tolley

About Robyn Tolley

Enterprising and strategic Director with operational executive experience in the European and global market place supplying software products and services and creating large scale transformation programmes for public and private sector organisations (Technology, Healthcare,Pharma, Public Sector, Outsourcing).

Commercially driven with a history of driving growth and profits by identifying process improvements and effectively managing change to maximise value of transformation programmes for large, complex organisations.

Related Story

Health Apps

 Nuance Dragon Medical One chosen by Guy's and St Thomas' NHS Foundation Trust | Pharmtech Focus

Guy's and St Thomas' NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation

April 28 2021

Nuance Communications, Inc. (NASDAQ: NUAN) today announced that Guy’s and St Thomas’ NHS Foundation Trust (the Trust) chose Nuance Dragon […]